Targeted, safe, and efficient gene delivery to human hematopoietic stem and progenitor cells in vivo using the engineered AVID adenovirus vector platform-Reference-Cited by-同舟云学术

Targeted, safe, and efficient gene delivery to human hematopoietic stem and progenitor cells in vivo using the engineered AVID adenovirus vector platform

Published:2024-01 Issue:1 Volume:32 Page:103-123
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Yao Jia,Atasheva Svetlana,Wagner Nicole,Di Paolo Nelson C.,Stewart Phoebe L.,Shayakhmetov Dmitry M.^ORCID

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference65 articles.

1. The promise and challenge of therapeutic genome editing;Doudna;Nature,2020

2. CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis;Gillmore;N. Engl. J. Med.,2021

3. Liver targeted gene therapy: Insights into emerging therapies;Moscoso;Drug Discov. Today Technol.,2019

4. Population dynamics of normal human blood inferred from somatic mutations;Lee-Six;Nature,2018

5. Therapy Development by Genome Editing of Hematopoietic Stem Cells;Koniali;Cells,2021

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Auto-expansion of in vivo HDAd-transduced hematopoietic stem cells by constitutive expression of tHMGA2;Molecular Therapy - Methods & Clinical Development;2024-09

2. Adeno-Associated Virus Vectors—a Target of Cellular and Humoral Immunity—are Expanding Their Reach Toward Hematopoietic Stem Cell Modification and Immunotherapies;Human Gene Therapy;2024-08-28

3. A simplified G-CSF–free procedure allows for in vivo HSC gene therapy of sickle cell disease in a mouse model;Blood Advances;2024-07-31

4. Stimulus-Responsive Nanodelivery and Release Systems for Cancer Gene Therapy: Efficacy Improvement Strategies;International Journal of Nanomedicine;2024-07

5. Smart Nanobiomaterials for Gene Delivery in Localized Cancer Therapy: An Overview from Emerging Materials and Devices to Clinical Applications;Current Cancer Drug Targets;2024-04-19